Nancy Miller-Rich

CIK 1735084 · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$727

Companies

4

Total Filings

24

Lifetime Open-Market Net

$10.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALDX Director 413 $1.76 $727 $10.4K 9 2026-06-11
FDMT Director $8.83 $0 5 2025-06-20
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Director 30,415 $19.00 $577.9K $0 6 2023-05-25
Kadmon Holdings, Inc. (KDMN) Delisted Director $9.50 $0 3 2021-11-09

Recent Filings · Page 2 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-09 ALDX Grant (A) $0 EDGAR
2022-05-27 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +7,737 $0 EDGAR
2022-05-25 FDMT Grant (A) $0 EDGAR
2021-11-09 Kadmon Holdings, Inc. (KDMN) Delisted Disp (D) $0 EDGAR
2021-06-10 ALDX Grant (A) $0 EDGAR
2021-06-01 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +7,029 $0 EDGAR
2021-05-19 FDMT Grant (A) $0 EDGAR
2021-05-13 Kadmon Holdings, Inc. (KDMN) Delisted Grant (A) $0 EDGAR
2020-08-13 Kadmon Holdings, Inc. (KDMN) Delisted Grant (A) $0 EDGAR
2020-06-11 ALDX Grant (A) $0 EDGAR
Showing 1120 of 24
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.